Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global PET Radiopharmaceuticals Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global PET Radiopharmaceuticals Market Status and Forecast (2016-2027)
      • 1.3.2 Global PET Radiopharmaceuticals Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global PET Radiopharmaceuticals Supply by Company

    • 2.1 Global PET Radiopharmaceuticals Sales Volume by Company
    • 2.2 Global PET Radiopharmaceuticals Sales Value by Company
    • 2.3 Global PET Radiopharmaceuticals Price by Company
    • 2.4 PET Radiopharmaceuticals Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional PET Radiopharmaceuticals Market Status by Category

    • 3.1 PET Radiopharmaceuticals Category Introduction
      • 3.1.1 F-18
      • 3.1.2 Ru-82
      • 3.1.3 Others
    • 3.2 Global PET Radiopharmaceuticals Market by Category
      • 3.2.1 Global PET Radiopharmaceuticals Sales Volume by Category (2016-2021)
      • 3.2.2 Global PET Radiopharmaceuticals Sales Value by Category (2016-2021)
      • 3.2.3 Global PET Radiopharmaceuticals Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional PET Radiopharmaceuticals Market Status by End User/Segment

    • 4.1 PET Radiopharmaceuticals Segment by End User/Segment
      • 4.1.1 Oncology
      • 4.1.2 Cardiology
      • 4.1.3 Neurology
      • 4.1.4 Others
    • 4.2 Global PET Radiopharmaceuticals Market by End User/Segment
      • 4.2.1 Global PET Radiopharmaceuticals Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global PET Radiopharmaceuticals Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global PET Radiopharmaceuticals Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global PET Radiopharmaceuticals Market Status by Region

    • 5.1 Global PET Radiopharmaceuticals Market by Region
      • 5.1.1 Global PET Radiopharmaceuticals Sales Volume by Region
      • 5.1.2 Global PET Radiopharmaceuticals Sales Value by Region
    • 5.2 North America PET Radiopharmaceuticals Market Status
    • 5.3 Europe PET Radiopharmaceuticals Market Status
    • 5.4 Asia Pacific PET Radiopharmaceuticals Market Status
    • 5.5 Central & South America PET Radiopharmaceuticals Market Status
    • 5.6 Middle East & Africa PET Radiopharmaceuticals Market Status

    6 North America PET Radiopharmaceuticals Market Status

    • 6.1 North America PET Radiopharmaceuticals Market by Country
      • 6.1.1 North America PET Radiopharmaceuticals Sales Volume by Country (2016-2021)
      • 6.1.2 North America PET Radiopharmaceuticals Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe PET Radiopharmaceuticals Market Status

    • 7.1 Europe PET Radiopharmaceuticals Market by Country
      • 7.1.1 Europe PET Radiopharmaceuticals Sales Volume by Country (2016-2021)
      • 7.1.2 Europe PET Radiopharmaceuticals Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific PET Radiopharmaceuticals Market Status

    • 8.1 Asia Pacific PET Radiopharmaceuticals Market by Country
      • 8.1.1 Asia Pacific PET Radiopharmaceuticals Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific PET Radiopharmaceuticals Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America PET Radiopharmaceuticals Market Status

    • 9.1 Central & South America PET Radiopharmaceuticals Market by Country
      • 9.1.1 Central & South America PET Radiopharmaceuticals Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America PET Radiopharmaceuticals Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa PET Radiopharmaceuticals Market Status

    • 10.1 Middle East & Africa PET Radiopharmaceuticals Market by Country
      • 10.1.1 Middle East & Africa PET Radiopharmaceuticals Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa PET Radiopharmaceuticals Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 PET Radiopharmaceuticals Manufacturing Cost Analysis
    • 11.5 PET Radiopharmaceuticals Sales Channel and Distributors Analysis
      • 11.5.1 PET Radiopharmaceuticals Sales Channel
      • 11.5.2 PET Radiopharmaceuticals Distributors
    • 11.6 PET Radiopharmaceuticals Downstream Major Buyers

    12 Global PET Radiopharmaceuticals Market Forecast by Category and by End User/Segment

    • 12.1 Global PET Radiopharmaceuticals Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global PET Radiopharmaceuticals Forecast by Category
      • 12.2.1 Global PET Radiopharmaceuticals Sales Volume Forecast by Category
      • 12.2.2 Global PET Radiopharmaceuticals Sales Value Forecast by Category
      • 12.2.3 Global PET Radiopharmaceuticals Price Forecast by Category
    • 12.3 Global PET Radiopharmaceuticals Forecast by End User/Segment
      • 12.3.1 Global PET Radiopharmaceuticals Sales Volume Forecast by End User/Segment
      • 12.3.2 Global PET Radiopharmaceuticals Sales Value Forecast by End User/Segment
      • 12.3.3 Global PET Radiopharmaceuticals Price Forecast by End User/Segment

    13 Global PET Radiopharmaceuticals Market Forecast by Region/Country

    • 13.1 Global PET Radiopharmaceuticals Market Forecast by Region (2022-2027)
      • 13.1.1 Global PET Radiopharmaceuticals Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global PET Radiopharmaceuticals Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Nordion, Inc. (Canada)
      • 14.1.1 Company Information
      • 14.1.2 PET Radiopharmaceuticals Product Introduction
      • 14.1.3 Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Mallinckrodt plc (Ireland)
      • 14.2.1 Company Information
      • 14.2.2 PET Radiopharmaceuticals Product Introduction
      • 14.2.3 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Lantheus Medical Imaging, Inc. (U.S.)
      • 14.3.1 Company Information
      • 14.3.2 PET Radiopharmaceuticals Product Introduction
      • 14.3.3 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 IBA Molecular Imaging (Belgium)
      • 14.4.1 Company Information
      • 14.4.2 PET Radiopharmaceuticals Product Introduction
      • 14.4.3 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 GE Healthcare (U.K.)
      • 14.5.1 Company Information
      • 14.5.2 PET Radiopharmaceuticals Product Introduction
      • 14.5.3 GE Healthcare (U.K.) PET Radiopharmaceuticals Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Eczacibasi-Monrol Nuclear Products (Turkey)
      • 14.6.1 Company Information
      • 14.6.2 PET Radiopharmaceuticals Product Introduction
      • 14.6.3 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Cardinal Health Inc. (U.S.)
      • 14.7.1 Company Information
      • 14.7.2 PET Radiopharmaceuticals Product Introduction
      • 14.7.3 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Bracco Imaging S.p.A (Italy)
      • 14.8.1 Company Information
      • 14.8.2 PET Radiopharmaceuticals Product Introduction
      • 14.8.3 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Bayer AG (Germany)
      • 14.9.1 Company Information
      • 14.9.2 PET Radiopharmaceuticals Product Introduction
      • 14.9.3 Bayer AG (Germany) PET Radiopharmaceuticals Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 Advanced Accelerator Applications S.A. (France)
      • 14.10.1 Company Information
      • 14.10.2 PET Radiopharmaceuticals Product Introduction
      • 14.10.3 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global PET Radiopharmaceuticals market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global PET Radiopharmaceuticals market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      F-18
      Ru-82
      Others

      Segmented by End User/Segment
      Oncology
      Cardiology
      Neurology
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Nordion, Inc. (Canada)
      Mallinckrodt plc (Ireland)
      Lantheus Medical Imaging, Inc. (U.S.)
      IBA Molecular Imaging (Belgium)
      GE Healthcare (U.K.)
      Eczacibasi-Monrol Nuclear Products (Turkey)
      Cardinal Health Inc. (U.S.)
      Bracco Imaging S.p.A (Italy)
      Bayer AG (Germany)
      Advanced Accelerator Applications S.A. (France)
      Buy now